Gene Therapy-Associated Uveitis (GTAU): Understanding and mitigating the adverse immune response in retinal gene therapy
Purdy R. et al, (2025), Progress in Retinal and Eye Research, 106, 101354 - 101354
CRISPR targeting of SNPs associated with age-related macular degeneration in ARPE-19 cells: a potential model for manipulating the complement system
Salman A. et al, (2025), Gene Therapy, 32, 132 - 141
Low-luminance visual acuity and low-luminance deficit: optimising measurement and analysis
Forte G. et al, (2025), Clinical and Experimental Optometry, 1 - 7
Gene therapy for choroideremia: progress, potential and pitfalls.
Abdalla Elsayed MEA. et al, (2025), Expert Opin Biol Ther, 1 - 7
XOLARIS: A 24-Month, Prospective, Natural History Study of 201 Participants with Retinitis Pigmentosa GTPase Regulator-Associated X-Linked Retinitis Pigmentosa
MacLaren RE. et al, (2025), Ophthalmology Science, 5, 100595 - 100595
Spontaneously Immortalised Nonhuman Primate Müller Glia Cell Lines as Source to Explore Retinal Reprogramming Mechanisms for Cell Therapies
Salman A. et al, (2024), Journal of Cellular Physiology
Retinal Patterns and the Role of Autofluorescence in Choroideremia.
Poli FE. et al, (2024), Genes (Basel), 15
Exploring Scotopic Microperimetry as an Outcome Measure in Choroideremia
Taylor LJ. et al, (2024), Translational Vision Science & Technology, 13, 29 - 29
Gene therapy in the early stages of retinal degeneration
MacLaren RE., (2024), The Lancet, 404, 911 - 913
Expanding the genotypic and phenotypic spectra with a novel variant in the ciliopathy gene, CFAP410, associated with selective cone degeneration.
Borchert GA. et al, (2024), Ophthalmic Genet, 1 - 7
Assessment of Visual Function with Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa in the Randomized XIRIUS Phase 2/3 Study
Lam BL. et al, (2024), Ophthalmology, 131, 1083 - 1093
Gene Therapies in Clinical Development to Treat Retinal Disorders
McClements ME. et al, (2024), Molecular Diagnosis & Therapy, 28, 575 - 591
Genetic therapies and potential therapeutic applications of CRISPR activators in the eye.
Ng BW. et al, (2024), Prog Retin Eye Res, 102
Retinal Focal Nodular Gliosis (Vasoproliferative Tumors) Have Varied Clinical Courses Requiring Tailored Management: A Case Series.
Ie A. et al, (2024), Ocul Oncol Pathol, 10, 175 - 181
Single-cell transcriptomic analysis of retinal immune regulation and blood-retinal barrier function during experimental autoimmune uveitis
Quinn J. et al, (2024), Scientific Reports, 14
Investigating the impact of asymmetric macular sensitivity on visual acuity chart reading in choroideremia
Baffour‐Awuah KA. et al, (2024), Ophthalmic and Physiological Optics
Robot-Assisted Eye Surgery: A Systematic Review of Effectiveness, Safety, and Practicality in Clinical Settings.
Thirunavukarasu AJ. et al, (2024), Transl Vis Sci Technol, 13